{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:14:37Z","timestamp":1780445677845,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejogrb.2015.06.006","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T12:05:49Z","timestamp":1434456349000},"page":"116-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Effects of low dose oral contraceptive pill containing drospirenone\/ethinylestradiol in patients with endometrioma"],"prefix":"10.1016","volume":"191","author":[{"given":"Fuminori","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Enatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiko","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Arata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2015.06.006_bib0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bpobgyn.2004.01.007","article-title":"Endometriosis: epidemiology and aetiological factors","volume":"18","author":"Vigano","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/aje\/kwq143","article-title":"Pelvic endometriosis diagnosed in an entire nation over 20 years","volume":"172","author":"Gylfason","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0185","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/humupd\/dmt016","article-title":"Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review","volume":"19","author":"Janssen","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0190","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/humrep\/des073","article-title":"The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres","volume":"27","author":"Simoens","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0195","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.AOG.0000265215.87717.8b","article-title":"Patterns of and risk factors for recurrence in women with ovarian endometriomas","volume":"109","author":"Liu","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/GCO.0b013e32835175d9","article-title":"Is there a benefit for surgery in endometrioma-associated infertility?","volume":"24","author":"Ruiz-Flores","year":"2012","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/humupd\/dmi049","article-title":"Advances in the management of endometriosis: an update for clinicians","volume":"12","author":"Crosignani","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0210","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0015-0282(02)03099-6","article-title":"Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis","volume":"77","author":"Meresman","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(03)13907-4","article-title":"Mortality in relation to oral contraceptive use and cigarette smoking","volume":"362","author":"Vessey","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0220","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/09513590.2011.634936","article-title":"A new oral contraceptive regimen for endometriosis management: preliminary experience with 24\/4-day drospirenone\/ethinylestradiol 3mg\/20mcg","volume":"28","author":"Mabrouk","year":"2012","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0230","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/13625180701440818","article-title":"A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight","volume":"12","author":"Endrikat","year":"2007","journal-title":"Eur J Contracept Reprod Health Care Off J Eur Soc Contracept"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0235","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejogrb.2010.12.027","article-title":"Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20mug plus drospirenone 3mg administered in a 24\/4 regimen: a pooled analysis","volume":"155","author":"Koltun","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0240","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0245","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9378(97)70553-2","article-title":"Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis","volume":"176","author":"Harada","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0250","first-page":"824","article-title":"Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression","volume":"85","author":"Iwabe","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0015-0282(99)00496-3","article-title":"Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues","volume":"73","author":"Tsudo","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0260","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1210\/jc.2002-020666","article-title":"Tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression","volume":"88","author":"Sakamoto","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0265","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fertnstert.2007.02.014","article-title":"Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance","volume":"88","author":"Seifer","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0270","first-page":"384","article-title":"Decrease in the size of ovarian endometriomas during ovarian suppression in stage IV endometriosis. Role of preoperative medical treatment","volume":"41","author":"Rana","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0275","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1447-0756.2009.01017.x","article-title":"The efficacy of preoperative hormonal therapy before laparoscopic cystectomy of ovarian endometriomas","volume":"35","author":"Tsujioka","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0015-0282(16)56039-7","article-title":"A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis","volume":"60","author":"Vercellini","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.mce.2009.04.012","article-title":"TAK1 activation for cytokine synthesis and proliferation of endometriotic cells","volume":"307","author":"Taniguchi","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0290","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/humrep\/dep464","article-title":"Rate of severe ovarian damage following surgery for endometriomas","volume":"25","author":"Benaglia","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0295","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/humrep\/deq069","article-title":"Direct proportional relationship between endometrioma size and ovarian parenchyma inadvertently removed during cystectomy, and its implication on the management of enlarged endometriomas","volume":"25","author":"Roman","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0300","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.fertnstert.2010.04.067","article-title":"Anti-Mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve","volume":"94","author":"Gleicher","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0305","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1210\/jc.2012-3995","article-title":"Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population-based study","volume":"98","author":"Dolleman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0310","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.rbmo.2012.09.001","article-title":"Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception","volume":"25","author":"Bentzen","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0315","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1477-7827-11-28","article-title":"Does hormonal contraception prior to in vitro fertilization (IVF) negatively affect oocyte yields? A pilot study","volume":"11","author":"Barad","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0320","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.contraception.2010.09.007","article-title":"Serum anti-mullerian hormone level is not altered in women using hormonal contraceptives","volume":"83","author":"Li","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2013.03.032","article-title":"One-year follow-up of serum antimullerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve?","volume":"100","author":"Sugita","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2015.06.006_bib0330","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/humrep\/deq071","article-title":"Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases","volume":"25","author":"van den Berg","year":"2010","journal-title":"Hum Reprod"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151500189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151500189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:35:27Z","timestamp":1759556127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151500189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":33,"alternative-id":["S030121151500189X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2015.06.006","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of low dose oral contraceptive pill containing drospirenone\/ethinylestradiol in patients with endometrioma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2015.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}